Bacil Pharma Ltd vs Colinz Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Bacil Pharma Ltd is ₹ 54.99 as of 05 May 15:30 . The P/E Ratio of Bacil Pharma Ltd changed from 146.5 on March 2025 to 146.5 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Colinz Laboratories Ltd changed from 12.9 on March 2021 to 36.8 on March 2025 . This represents a CAGR of 23.33% over 5 years The Market Cap of Bacil Pharma Ltd changed from ₹ 1.84 crore on March 2021 to ₹ 60.99 crore on March 2025 . This represents a CAGR of 101.41% over 5 yearsThe Market Cap of Colinz Laboratories Ltd changed from ₹ 3.47 crore on March 2021 to ₹ 33.11 crore on March 2025 . This represents a CAGR of 57.01% over 5 years The revenue of Bacil Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0.06 crore. This represent the decline of -100% The revenue of Colinz Laboratories Ltd for the Mar '26 is ₹ 1.92 crore as compare to the Dec '25 revenue of ₹ 1.51 crore. This represent the growth of 27.15% The ebitda of Bacil Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0.04 crore. This represent the decline of -100% The ebitda of Colinz Laboratories Ltd for the Mar '26 is ₹ 0.27 crore as compare to the Dec '25 ebitda of ₹ 0.18 crore. This represent the growth of 50% The net profit of Bacil Pharma Ltd changed from ₹ -0.03 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Colinz Laboratories Ltd changed from ₹ 0.14 crore to ₹ 0.17 crore over 8 quarters. This represents a CAGR of 10.19% The Dividend Payout of Bacil Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Colinz Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bacil Pharma Ltd

Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90.
The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs.
Domestic operations are spread across pan India.
The company has strong field force of 500 plus, spread over various States and Districts.
It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage.

About Colinz Laboratories Ltd

Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986.
The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995.
The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc.
The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc.
Since, the Company falls under the MSME sector, it established reputation as a quality supplier of medicines in the domestic market, wherever the Company has operation. Apart from this, the Company has a WHO compliant plant at Sinnar.

FAQs for the comparison of Bacil Pharma Ltd and Colinz Laboratories Ltd

Which company has a larger market capitalization, Bacil Pharma Ltd or Colinz Laboratories Ltd?

Market cap of Bacil Pharma Ltd is 78 Cr while Market cap of Colinz Laboratories Ltd is 6 Cr

What are the key factors driving the stock performance of Bacil Pharma Ltd and Colinz Laboratories Ltd?

The stock performance of Bacil Pharma Ltd and Colinz Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bacil Pharma Ltd and Colinz Laboratories Ltd?

As of May 5, 2026, the Bacil Pharma Ltd stock price is INR ₹54.99. On the other hand, Colinz Laboratories Ltd stock price is INR ₹50.0.

How do dividend payouts of Bacil Pharma Ltd and Colinz Laboratories Ltd compare?

To compare the dividend payouts of Bacil Pharma Ltd and Colinz Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.